From July 20, 2023 to September 8, 2023, the company has repurchased 5,323,451 shares, representing 21.86% for $3.73 million. With this, the company has completed the repurchase of 5,323,451 shares, representing 21.86% for $3.73 million under the buyback announced on July 20, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.68 USD | +8.93% | +10.98% | +3.78% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.78% | 8.01M | |
+3.91% | 108B | |
+10.87% | 104B | |
+1.28% | 22.33B | |
-13.14% | 22.19B | |
-7.05% | 18.69B | |
-38.36% | 17.74B | |
-10.66% | 17.64B | |
+3.75% | 14.05B | |
+36.70% | 12.51B |
- Stock Market
- Equities
- KTTA Stock
- News Pasithea Therapeutics Corp.
- Tranche Update on Pasithea Therapeutics Corp.'s Equity Buyback Plan announced on July 20, 2023.